Antigen-Specific Adaptive Immunity to SARS-CoV-2 in Acute COVID-19 and Associations with Age and Disease Severity

Cited by (1,001)

Items 801–900 of 1,001

1. Insights into Pathology and Pathogenesis of Coronavirus Disease 2019 from a Histopathological and Immunological Perspective
   Shun Iida, Takeshi Arashiro, Tadaki Suzuki · 2021 · JMA Journal
2. Virus-Induced CD8+ T-Cell Immunity and Its Exploitation to Contain the SARS-CoV-2 Pandemic
   Maurizio Federico · 2021 · Vaccines
3. Specific CD4+ T Cell Responses to Ancestral SARS-CoV-2 in Children Increase With Age and Show Cross-Reactivity to Beta Variant
   Kevin Paul, Freya Sibbertsen, Daniela Weiskopf, Marc Lütgehetmann, Madalena Barroso, Marta K. Danecka, Laura Glau, Laura Hecher, Katharina Hermann, Aloisa Kohl et al. · 2022 · Frontiers in Immunology
4. Waning cellular immune responses and predictive factors in maintaining cellular immunity against SARS-CoV-2 six months after BNT162b2 mRNA vaccination
   Takashi Ishii, Kensuke Hamada, Daisuke Jubishi, Hideki Hashimoto, Koh Okamoto, Naoko Hisasue, Mitsuhiro Sunohara, Minako Saito, Takayuki Shinohara, Marie Yamashita et al. · 2023 · Scientific Reports
5. A Longitudinal Molecular and Cellular Lung Atlas of Lethal SARS-CoV-2 Infection in K18-hACE2 Transgenic Mice
   Seung-Hoon Choi, Jusung Lee, Suhyeon Kim, Youn Woo Lee, Gi-Cheon Kim, Seung-Min Hong, Se-Hee An, Hyuna Noh, Kyung Eun Kim, Dain On et al. · 2022 · EBioMedicine
6. What makes SARS‐CoV‐2 unique? Focusing on the spike protein
   Jingbo Qian, Shi-Chang Zhang, Fang Wang, Jinming Li, Jiexin Zhang · 2024 · Cell Biology International
7. IFN-λ uniquely promotes CD8 T cell immunity against SARS-CoV-2 relative to type I IFN
   Abigail Solstad, Parker J. Denz, Adam D. Kenney, Najmus S. Mahfooz, Samuel Speaks, Qiaoke Gong, Richard Robinson, Matthew E. Long, Adriana Forero, Jacob S. Yount et al. · 2024 · JCI Insight
8. The role of inflammatory gene polymorphisms in severe COVID-19: a review
   Jia Qi Yip, Adrian Oo, Yan Ling Ng, Kim Ling Chin, Kim‐Kee Tan, Justin Jang Hann Chu, Sazaly AbuBakar, Nurhafiza Zainal · 2024 · Virology Journal
9. T Helper 17 Response to Severe Acute Respiratory Syndrome Coronavirus 2: A Type of Immune Response with Possible Therapeutic Implications
   Juan Camilo Sarmiento-Monroy, Rafael Santiago Parra-Medina, Édgar Garavito, Adriana Rojas‐Villarraga · 2021 · Viral Immunology
10. Uremia-Associated Immunological Aging and Severity of COVID-19 Infection
    Michiel G.H. Betjes · 2021 · Frontiers in Medicine
11. COVID-19 in Patients with Hematologic Malignancies: Outcomes and Options for Treatments
    José Carlos Martínez, Roberto Alejandro Sica, Keith E Stockerl-Goldstein, Samuel M. Rubinstein · 2022 · Acta Haematologica
12. Durable T-cellular and humoral responses in SARS-CoV-2 hospitalized and community patients
    Kristin Greve-Isdahl Mohn, Geir Bredholt, Fan Zhou, Anders Madsen, Therese Bredholt Onyango, Elisabeth Berg Fjelltveit, Sarah Larteley Lartey, Karl Albert Brokstad, Diego M. Cantoni, Martin Mayora Neto et al. · 2022 · PLoS ONE
13. Preserved SARS-CoV-2 Vaccine Cell-Mediated Immunogenicity in Patients With Inflammatory Bowel Disease on Immune-Modulating Therapies
    Brigid Sweeney Boland, Benjamin Goodwin, Zeli Zhang, Nathaniel I. Bloom, Yu Kato, Jennifer Neill, Helen Le, Tiffani Tysl, Angelina E. Collins, Parambir Singh Dulai et al. · 2022 · Clinical and Translational Gastroenterology
14. COVID-19 mRNA Vaccine in Patients With Lymphoid Malignancy or Anti-CD20 Antibody Therapy: A Systematic Review and Meta-Analysis
    Yusuke Ito, Akira Honda, Mineo Kurokawa · 2022 · Clinical Lymphoma Myeloma & Leukemia
15. Defining Clinical and Immunological Predictors of Poor Immune Responses to COVID-19 mRNA Vaccines in Patients with Primary Antibody Deficiency
    Junghee J. Shin, Jennefer Par‐Young, Serhan Ünlü, Andrew McNamara, Hong‐Jai Park, Min Sun Shin, Renelle J. Gee, Hester A. Doyle, Yuliya Afinogenova, Elena Zidan et al. · 2022 · Journal of Clinical Immunology
16. A Complementary Union of SARS-CoV2 Natural and Vaccine Induced Immune Responses
    Joseph Torresi, Melissa Anne Edeling, Terry M. Nolan, Dale Ian Godfrey · 2022 · Frontiers in Immunology
17. Patients Recovering from Severe COVID-19 Develop a Polyfunctional Antigen-Specific CD4+ T Cell Response
    Annamaria Paolini, Rebecca Borella, Anita Neroni, Domenico Lo Tartaro, Marco Mattioli, Lucia Fidanza, Alessia Di Nella, Elena Santacroce, Licia Gozzi, Stefano Busani et al. · 2022 · International Journal of Molecular Sciences
18. Mitochondrial regulation of acute extrafollicular B‐cell responses to COVID‐19 severity
    Tianyu Cao, Li Liu, Kelvin Kai‐Wang To, Chun‐Yu Lim, Runhong Zhou, Yue Ming, Ka‐Yi Kwan, Sulan Yu, Chun‐Yin Chan, Biao Zhou et al. · 2022 · Clinical and Translational Medicine
19. Immunogenicity, efficacy, and safety of SARS-CoV-2 vaccine dose fractionation: a systematic review and meta-analysis
    Bingyi Yang, Xiaotong Huang, Huizhi Gao, Nancy Leung, Tim K. Tsang, Benjamin John Cowling · 2022 · BMC Medicine
20. Identification of COVID-19 severity biomarkers based on feature selection on single-cell RNA-Seq data of CD8+ T cells
    Jian Lu, Mei Meng, Xianchao Zhou, Shi‐Jian Ding, Kaiyan Feng, Zhenbing Zeng, Tao Huang, Yu‐Dong Cai · 2022 · Frontiers in Genetics
21. Robust humoral and cellular recall responses to AZD1222 attenuate breakthrough SARS-CoV-2 infection compared to unvaccinated
    Jill Maaske, Stephanie Sproule, Ann Regina Falsey, Magdalena E. Sobieszczyk, Anne F. Luetkemeyer, Grant C. Paulsen, Sharon A. Riddler, Merlin Lee Robb, Charlotte-Paige Rolle, Beverly E. Sha et al. · 2023 · Frontiers in Immunology
22. Recuperative herbal formula Jing Si maintains vasculature permeability balance, regulates inflammation and assuages concomitants of “Long-Covid”
    Chien-Yi Chiang, Yu‐Jung Lin, Wen‐Tsan Weng, Heng-Dao Lin, Cheng‐You Lu, Wan‐Jing Chen, Cheng Yen Shih, Pi‐Yu Lin, Shinn‐Zong Lin, Tsung-Jung Ho et al. · 2023 · Biomedicine & Pharmacotherapy
23. IFN‐γ+ cell response and IFN‐γ release concordance after in vitro SARS‐CoV‐2 stimulation
    Alejandro Vallejo, Pilar Vizcarra, Carmen Quereda, Ana Maria Moreno, José L. Casado, the CoVEX study group · 2021 · European Journal of Clinical Investigation
24. Prolonged SARS-CoV-2 infection associated with long-term corticosteroid use in a patient with impaired B-cell immunity
    Momoko Morishita, Manabu Suzuki, Akihiro Matsunaga, Keishi Ishizhima, Tsukasa Yamamoto, Yudai Kuroda, Takayuki Kanno, Yoshie Tsujimoto, Akane Ishida, Masao Hashimoto et al. · 2022 · Journal of Infection and Chemotherapy
25. T-cell exhaustion in COVID-19: what do we know?
    Roderick Chen-Camaño, Rodrigo DeAntonio, Sandra López‐Vergès · 2025 · Frontiers in Immunology
26. Long-Term Immunity and Antibody Response: Challenges for Developing Efficient COVID-19 Vaccines
    Mohammad Reza Sepand, Banafsheh Bigdelou, Jim Q. Ho, Mohammad Sharaf, Alexis J. Lannigan, Ian M. Sullivan, Alecsander P. da Silva, Leland O. Barrett, Scott McGoldrick, Yuvraj Lnu et al. · 2022 · Antibodies
27. Lung T cell response in COVID-19
    Mehrnoush Hadaddzadeh Shakiba, Ioanna D. Gemünd, Marc Beyer, Lorenzo Bonaguro · 2023 · Frontiers in Immunology
28. A unique cytotoxic CD4 + T cell‐signature defines critical COVID‐19
    Sarah Baird, Caroline L. Ashley, Felix Marsh‐Wakefield, Sibel Alca, Thomas M. Ashhurst, Angela L. Ferguson, Hannah Lukeman, Claudio Counoupas, Jeffrey John Post, Pam Koneçny et al. · 2023 · Clinical & Translational Immunology
29. Association between BNT162b2 and CoronaVac vaccination and risk of CVD and mortality after COVID-19 infection: A population-based cohort study
    Eric Yuk Fai Wan, Anna Hoi Ying Mok, Vincent Ka Chun Yan, Cheyenne I Ying Chan, Boyuan Wang, Francisco Tsz Tsun Lai, Celine Sze Ling Chui, Xue Li, Carlos King Ho Wong, Kai Hang Yiu et al. · 2023 · Cell Reports Medicine
30. The Influence of Cross-Reactive T Cells in COVID-19
    Peter J. Eggenhuizen, Joshua Daniel Ooi · 2024 · Biomedicines
31. Longitudinal Evaluation of Severe Acute Respiratory Syndrome Coronavirus 2 T-Cell Immunity Over 2 Years Following Vaccination and Infection
    Anna Karina Juhl, Lisa Loksø Dietz, Ole Schmeltz Søgaard, Joanne Reekie, Henrik Ib Nielsen, Işık Somuncu Johansen, Thomas Benfield, Lothar Wiese, Nina Breinholt Stærke, Tomas Østergaard Jensen et al. · 2024 · The Journal of Infectious Diseases
32. Cytokine profile of anti-spike CD4+T cells predicts humoral and CD8+T cell responses after anti-SARS-CoV-2 mRNA vaccination
    Nadine Benhamouda, Anissa Besbes, Rebecca Bauer, Nesrine Mabrouk, Gauthier Gadouas, Corinne Desaint, Lucie Chevrier, Maeva Lefebvre, Anne Radenne, Marie Roelens et al. · 2024 · iScience
33. Immune responses in COVID-19 patients: Insights into cytokine storms and adaptive immunity kinetics
    Jun-Guo Zhang · 2024 · Heliyon
34. Nucleic acid vaccines: innovations, efficacy, and applications in at-risk populations
    Emily Konopka, Arden O. Edgerton, Michele A. Kutzler · 2025 · Frontiers in Immunology
35. Illuminating the immunopathology of SARS‐CoV ‐2
    Suraj Saksena, Pratip K. Chattopadhyay · 2021 · Cytometry Part B Clinical Cytometry
36. IFN-γ-mediated control of SARS-CoV-2 infection through nitric oxide
    Bruno J. de Andrade Silva, Paul A. Krogstad, Rosane M. B. Teles, Priscila R. Andrade, Jacob Rajfer, Monica G. Ferrini, Otto O. Yang, Barry R. Bloom, Robert L. Modlin · 2023 · Frontiers in Immunology
37. Persistence of immunogenicity, contributing factors of an immune response, and reactogenicities after a single dose of the ChAdOx1 (AZD1222) COVID-19 vaccine in the Thai population
    K. Tawinprai, T. Siripongboonsitti, T. Porntharukchareon, Bothamai Dechates, Harnphadungkit Monprach, G. Sornsamdang, K. Wittayasak, K. Soonklang, N. Mahanonda · 2022 · Human Vaccines & Immunotherapeutics
38. The Relative Positioning of B and T Cell Epitopes Drives Immunodominance
    Riccardo Biavasco, Marco De Giovanni · 2022 · Vaccines
39. Health influence of SARS-CoV-2 (COVID-19) on cancer: a review
    Rachel Parise, Yiran E Li, Rishi M. Nadar, Sindhu Ramesh, Jun Ren, Manoj Govindarajulu, Timothy M. Moore, Muralikrishnan Dhanasekaran · 2022 · Acta Biochimica et Biophysica Sinica
40. Bamlanivimab therapy for acute COVID-19 does not blunt SARS-CoV-2–specific memory T cell responses
    Sydney I. Ramirez, Alba Grifoni, Daniela Weiskopf, Urvi M. Parikh, Amy Heaps, Farhoud Faraji, Scott F. Sieg, Justin Ritz, Carlee Moser, Joseph J. Eron et al. · 2022 · JCI Insight
41. Meet changes with constancy: Defence, antagonism, recovery, and immunity roles of extracellular vesicles in confronting SARS‐CoV‐2
    Xiaohang Chen, Huifei Li, Haoyue Song, Jie Wang, Xiaoxuan Zhang, Pengcheng Han, Xing Wang · 2022 · Journal of Extracellular Vesicles
42. Enhanced Spike-specific, but attenuated Nucleocapsid-specific T cell responses upon SARS-CoV-2 breakthrough versus non-breakthrough infections
    Mohamed I. M. Ahmed, Paulina Diepers, Christian Janke, Michael Plank, Tabea M. Eser, Raquel Rubio‐Acero, Anna Fuchs, Olga Baranov, Noemi Castelletti, Inge Kroidl et al. · 2022 · Frontiers in Immunology
43. Dysfunctional Sars-CoV-2-M protein-specific cytotoxic T lymphocytes in patients recovering from severe COVID-19
    Hideki Ogura, Jin Gohda, Xiuyuan Lu, Mizuki Yamamoto, Yoshio Takesue, Aoi Son, Sadayuki Doi, Kazuyuki Matsushita, Fumitaka Isobe, Yoshihiro Fukuda et al. · 2022 · Nature Communications
44. Diagnostic performance between in-house and commercial SARS-CoV-2 serological immunoassays including binding-specific antibody and surrogate virus neutralization test (sVNT)
    Poramed Winichakoon, Jiraprapa Wipasa, Kriangkrai Chawansuntati, Parichat Salee, Tavitiya Sudjaritruk, Saowaluck Yasri, Chantana Khamwan, Rungnapa Peerakam, Dararat Dankai, Romanee Chaiwarith · 2023 · Scientific Reports
45. A flow cytometry-based proliferation assay for clinical evaluation of T-cell memory against SARS-CoV-2
    Sara Lind Enoksson, Peter Bergman, Jonas Klingström, Fredrik Boström, Rui Da Silva Rodrigues, Malin Elisabeth Winerdal, Per Marits · 2021 · Journal of Immunological Methods
46. Similar Risk of Severe Acute Respiratory Syndrome Coronavirus 2 Infection and Similar Nucleocapsid Antibody Levels in People With Well-Controlled Human Immunodeficiency Virus (HIV) and a Comparable Cohort of People Without HIV
    Myrthe L. Verburgh, Anders C. Boyd, Ferdinand W.N.M. Wit, Maarten F. Schim van der Loeff, Marc van der Valk, Margreet E. Bakker, Neeltje A. Kootstra, Lia van der Hoek, Peter Reiss · 2021 · The Journal of Infectious Diseases
47. T cell responses to SARS-CoV-2 in humans and animals
    Sameer-ul-Salam Mattoo, Jinjong Myoung · 2022 · The Journal of Microbiology
48. Deciphering the quality of SARS‐CoV‐2 specific T‐cell response associated with disease severity, immune memory and heterologous response
    Alberto Pérez‐Gómez, Carmen Gasca‐Capote, Joana Vitallé, Francisco José Ostos, Ana Serna‐Gallego, María Trujillo‐Rodríguez, Esperanza Muñoz‐Muela, Teresa Giráldez‐Pérez, Julia Praena‐Segovia, María Dolores Navarro-Amuedo et al. · 2022 · Clinical and Translational Medicine
49. Differential requirement of neutralizing antibodies and T cells on protective immunity to SARS-CoV-2 variants of concern
    Patrick Orestes de Azevedo, Natália Satchiko Hojo-Souza, Lídia Faustino, Marcílio Jorge Fumagalli, Isabella Cristina Hirako, Emiliano Rosa Oliveira, Maria M. Figueiredo, Alex Fiorini de Carvalho, Daniel Doro, Luciana Benevides et al. · 2023 · npj Vaccines
50. Liver and Kidney Function Biomarkers, Blood Cell Traits and Risk of Severe COVID-19: A Mendelian Randomization Study
    Kai Wang, Minghan Qu, Lin Ding, Xian Shi, Chaolong Wang, Shanshan Cheng, Xingjie Hao · 2021 · Frontiers in Genetics
51. Gene Expression Risk Scores for COVID-19 Illness Severity
    Derick R. Peterson, Andrea M Baran, Soumyaroop Bhattacharya, Angela Ramon Branche, Daniel P. Croft, Anthony M. Corbett, Edward E. Walsh, Ann Regina Falsey, Thomas J. Mariani · 2021 · The Journal of Infectious Diseases
52. Immunology and Technology of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccines
    Simone Pecetta, Sven Kratochvil, Yu Kato, Kumaran Vadivelu, Rino Rappuoli · 2022 · Pharmacological Reviews
53. Long-Term, CD4+ Memory T Cell Response to SARS-CoV-2
    Sebastian Wirsching, Laura H. Harder, Markus Heymanns, Britta Gröndahl, Katja Hilbert, Frank Kowalzik, Claudius U. Meyer, Stephan Gehring · 2022 · Frontiers in Immunology
54. pcMSC Modulates Immune Dysregulation in Patients With COVID-19-Induced Refractory Acute Lung Injury
    Mei-Chuan Chen, Kevin Shu-Leung Lai, Ko-Ling Chien, Sing-Teck Teng, Yuh-Rong Lin, Wei Chao, Meng-Jung Lee, Po‐Li Wei, Yen‐Hua Huang, Han‐Pin Kuo et al. · 2022 · Frontiers in Immunology
55. A Pilot Trial of Thymalfasin (Thymosin-α-1) to Treat Hospitalized Patients With Hypoxemia and Lymphocytopenia Due to Coronavirus Disease 2019 Infection
    Fadi Shehadeh, Gregorio Benitez, Evangelia K. Mylona, Quynh‐Lam Tran, Maria Tsikala-Vafea, Eleftheria Atalla, Matthew Kaczynski, Eleftherios E Mylonakis · 2022 · The Journal of Infectious Diseases
56. Activation‐induced marker assays for identification of Trypanosoma cruzi ‐specific CD4 or CD8 T cells in chronic Chagas disease patients
    Fátima Ferragut, Karen M. Cruz, Juan Pablo Gallardo, Marisa Liliana Fernandez, Yolanda Hernández Vasquez, Karina A. Gómez · 2022 · Immunology
57. Whole transcriptome analysis to explore the impaired immunological features in critically ill elderly patients with sepsis
    I‐Chieh Chen, Hsin‐Hua Chen, Yuhan Jiang, Tzu‐Hung Hsiao, Tai‐Ming Ko, Wen‐Cheng Chao · 2023 · Journal of Translational Medicine
58. Considerations for Choosing T Cell Assays during a Pandemic
    Jaclyn C. Law, Tania H. Watts · 2023 · The Journal of Immunology
59. Modeling the Within-Host Dynamics of SARS-CoV-2 Infection Based on Antiviral Treatment
    Tianqi Song, Yishi Wang, Xi Gu, Sijia Qiao · 2023 · Mathematics
60. Correlative CD4 and CD8 T-cell immunodominance in humans and mice: Implications for preclinical testing
    Tertuliano Alves Pereira Neto, John Sidney, Alba Grifoni, Alessandro Sette · 2023 · Cellular and Molecular Immunology
61. The longitudinal characterization of immune responses in COVID-19 patients reveals novel prognostic signatures for disease severity, patients’ survival and long COVID
    Maddalena Noviello, Rebecca DE LORENZO, Raniero Chimienti, Norma Maugeri, Claudia de Lalla, Gabriel Siracusano, Nicola Ivan Lorè, Paola M. V. Rancoita, Federica Cugnata, Elena Tassi et al. · 2024 · Frontiers in Immunology
62. Three doses of Sars-CoV-2 mRNA vaccine in older adults result in similar antibody responses but reduced cellular cytokine responses relative to younger adults
    Geir Bredholt, Marianne Sævik, Hanne Søyland, Thor Ueland, Fan Zhou, Rishi D. Pathirana, Anders Madsen, Juha Vahokoski, Sarah Larteley Lartey, Bente Lise Halvorsen et al. · 2024 · Vaccine X
63. Influence of Th1 versus Th2 immune bias on viral, pathological, and immunological dynamics in SARS-CoV-2 variant-infected human ACE2 knock-in mice
    Shailendra Kumar Verma, Fernanda Ana‐Sosa‐Batiz, Julia Timis, Norazizah Shafee, Erin Maule, Paolla Beatriz Almeida Pinto, Chris Conner, Kristen M. Valentine, Dale O. Cowley, Robyn Miller et al. · 2024 · EBioMedicine
64. Age-associated differences in mucosal and systemic host responses to SARS-CoV-2 infection
    Jillian H. Hurst, Aditya A Mohan, Trisha Dalapati, Ian A. George, Jhoanna N. Aquino, Debra J. Lugo, Trevor S. Pfeiffer, Javier Rodriguez, Alexandre Tellechea Rotta, Nicholas Turner et al. · 2025 · Nature Communications
65. The immunopathogenesis of SARS-CoV-2 infection: Overview of lessons learned in the first 5 years
    Otto O. Yang · 2025 · The Journal of Immunology
66. Highly conserved Betacoronavirus sequences are broadly recognized by human T cells
    Tertuliano Alves Pereira Neto, Christian M. Zmasek, Liliana Avalos, John Sidney, Raphael Trevizani, Elizabeth Jane Phillips, Simon Alexander Mallal, April Frazier, Gene S. Tan, Richard H. Scheuermann et al. · 2025 · Cell
67. Ageing of T-dependent B cell responses
    Fanny Martinez, Julien Novarino, José Enrique Mejía, Nicolas Fazilleau, Meryem Aloulou · 2021 · Immunology Letters
68. Long-Term SARS-CoV-2 Specific Immunity Is Affected by the Severity of Initial COVID-19 and Patient Age
    Margarethe Konik, Monika Lindemann, Markus Zettler, Lara Meller, Sebastian Dolff, Vera Rebmann, Peter Alexander Horn, Ulf Dittmer, Adalbert Krawczyk, Leonie Schipper et al. · 2021 · Journal of Clinical Medicine
69. High Frequencies of Functional Virus-Specific CD4+ T Cells in SARS-CoV-2 Subjects With Olfactory and Taste Disorders
    Dalila Mele, Anna Calastri, Eugenia Maiorano, Antonella Cerino, Michele Sachs, Barbara Oliviero, Stefania Mantovani, Fausto Baldanti, Raffaele Bruno, Marco Benazzo et al. · 2021 · Frontiers in Immunology
70. Immunouniverse of SARS-CoV-2
    Dennis Jiménez, Marbel Torres Arias · 2022 · Immunological Medicine
71. Predicted impact of the viral mutational landscape on the cytotoxic response against SARS-CoV-2
    Anna Foix, Daniel López, Francisco Díez‐Fuertes, Michael J. McConnell, Antonio J. Martín-Galiano · 2022 · PLoS Computational Biology
72. Comparison of two T-cell assays to evaluate T-cell responses to SARS-CoV-2 following vaccination in naïve and convalescent healthcare workers
    Eloise Phillips, Sandra Adele, Tom Malone, Alexandra S. Deeks, Lizzie Stafford, Susan L. Dobson, Ali Amini, Donal Skelly, David W. Eyre, Katie JM Jeffery et al. · 2022 · Clinical & Experimental Immunology
73. Proinflammatory Innate Cytokines and Distinct Metabolomic Signatures Shape the T Cell Response in Active COVID-19
    Akshay Binayke, Aymaan Zaheer, Jyotsna Dandotiya, Sonu Kumar Gupta, Shailendra Mani, Manas Ranjan Tripathy, Upasna Madan, Tripti Shrivastava, Yashwant Kumar, Anil Kumar Pandey et al. · 2022 · Vaccines
74. Severe SARS-Cov2 pneumonia in vaccinated patients: a multicenter cohort study
    Adrien Mirouse, Alice Friol, Anne‐Sophie Moreau, Boris Jung, Edouard Jullien, Côme Bureau, Michel Djibré, Nicolas de Prost, Lara Zafrani, Laurent Argaud et al. · 2023 · Scientific Reports
75. A longitudinal analysis of humoral, T cellular response and influencing factors in a cohort of healthcare workers: Implications for personalized SARS-CoV-2 vaccination strategies
    Eleonora Sabetta, Maddalena Noviello, Clara Sciorati, Marco Viganò, Rebecca DE LORENZO, Valeria Beretta, Veronica Valtolina, Chiara Di Resta, Giuseppe Banfi, Davide Ferrari et al. · 2023 · Frontiers in Immunology
76. Immunity following SARS-CoV-2 vaccination in autoimmune neurological disorders treated with rituximab or ocrelizumab
    Petra Nytrová, Dominika Šťastná, Adam Tesař, Ingrid Menkyová, Helena Posová, H Kopřivová, Veronika Mikulová, Jiří Hrdý, Gabriela Smelá, Dana Horáková et al. · 2023 · Frontiers in Immunology
77. T cell control of SARS-CoV-2: When, which, and where?
    Mariana O. Diniz, Mala K. Maini, Leo Swadling · 2023 · Seminars in Immunology
78. Comparing the immune abnormalities in MIS-C to healthy children and those with inflammatory disease reveals distinct inflammatory cytokine production and a monofunctional T cell response
    Claire Butters, Ntombi Benede, Thandeka Moyo-Gwete, Simone I. Richardson, Ursula Karin Rohlwink, Muki Shehu Shey, Frances Ayres, Nelia P. Manamela, Zanele Makhado, Sashkia R. Balla et al. · 2023 · Clinical Immunology
79. SARS-CoV-2 Portrayed against HIV: Contrary Viral Strategies in Similar Disguise
    Ralf Duerr, Keaton M. Crosse, Ana M. Valero-Jimenez, Meike Dittmann · 2021 · Microorganisms
80. Differences in SARS-CoV-2 Vaccine Response Dynamics Between Class-I- and Class-II-Specific T-Cell Receptors in Inflammatory Bowel Disease
    Alexander M. Xu, Dalin Li, Joseph E. Ebinger, Emebet Mengesha, Rebecca Elyanow, Rachel Gittelman, Heidi Chapman, Sandy Y. Joung, Gregory J. Botwin, Valeriya Pozdnyakova et al. · 2022 · Frontiers in Immunology
81. SARS-CoV-2 the ASIA virus (Autoimmune/autoinflammatory Syndrome Induced by Adjuvants), the risk of infertility and vaccine hesitancy
    Rohan Ameratunga · 2022 · Expert Review of Vaccines
82. COVID-19 patients exhibit unique transcriptional signatures indicative of disease severity
    Andrea R. Daamen, Prathyusha Bachali, Catherine A. Bonham, Lindsay Somerville, Jeffrey M. Sturek, Amrie C. Grammer, Alexandra Kadl, Peter E. Lipsky · 2022 · Frontiers in Immunology
83. IgG Antibodies against SARS-CoV-2 Correlate with Days from Symptom Onset, Viral Load and IL-10
    Mary K. Young, Christine M. Kornmeier, Rebecca M. Carpenter, Nick R. Natale, Jennifer M. Sasson, Michael D. Solga, Amy J. Mathers, Melinda D. Poulter, Xiao Qiang, William A. Petri · 2020 · medRxiv
84. SARS-CoV-2 T cell responses are expected to remain robust against Omicron
    Syed Faraz Ahmed, Ahmed Abdul Quadeer, Matthew R. McKay · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
85. Renaissance of antiviral CD8+ T cell immunity in vaccination and disease
    Victor Appay, Takuya Yamamoto, Asier Sáez‐Cirión · 2026 · Nature reviews. Immunology
86. In-depth analysis of T cell immunity and antibody responses in heterologous prime-boost-boost vaccine regimens against SARS-CoV-2 and Omicron variant
    Natalie Heinen, Corinna Sophie Marheinecke, Clara Bessen, Arturo Blazquez‐Navarro, Toralf Roch, Ulrik Stervbo, Moritz Anft, Carlos Plaza‐Sirvent, Sandra Buße, Mara Klöhn et al. · 2022 · Frontiers in Immunology
87. Effectiveness of mRNA and viral‐vector vaccines in epidemic period led by different SARS‐CoV‐2 variants: A systematic review and meta‐analysis
    Jun Zhang, Wenxing Yang, Feijun Huang, Kui Zhang · 2023 · Journal of Medical Virology
88. Immunogen-Specific Strengths and Limitations of the Activation-Induced Marker Assay for Assessing Murine Antigen-Specific CD4+ T Cell Responses
    Nguyen X. Nguyen, Andrew W. Richens, Linda M. Sircy, Denise Allard, Elizabeth Motunrayo Kolawole, Brian D. Evavold, Maria Bettini, J. Scott Hale · 2023 · The Journal of Immunology
89. High-dimensional comparison of monocytes and T cells in post-COVID and idiopathic pulmonary fibrosis
    Grace C. Bingham, Lyndsey M. Muehling, Chaofan Li, Yong Huang, Shwu‐Fan Ma, Daniel Abebayehu, Imre Noth, Jie Sun, Judith A. Woodfolk, Thomas Harrison Barker et al. · 2024 · Frontiers in Immunology
90. Protecting the vulnerable: addressing the COVID-19 care needs of people with compromised immunity
    Raymund Rabe Razonable · 2024 · Frontiers in Immunology
91. Preschool-age children maintain a distinct memory CD4 + T cell and memory B cell response after SARS-CoV-2 infection
    Benoît Manfroi, Bui Thi Cuc, Aurélien Sokal, Alexis Vandenberghe, Sarah Temmam, Mikaël Attia, Mohamed El Behi, Francesco Camaglia, Ngan Thu Nguyen, Jelka Pohar et al. · 2024 · Science Translational Medicine
92. Metabolic T-cell phenotypes: from bioenergetics to function
    Nouria Jantz-Naeem, Nese Guvencli, Romy Loschinski, Martin Böttcher, Dimitrios Mougiakakos, Sascha Kahlfuß · 2025 · American Journal of Physiology-Cell Physiology
93. Vaccine-induced T cell responses correlate with reduced risk of severe COVID-19 in a placebo-controlled efficacy trial
    Nina Hertoghs, Sanne Roels, Matthias Brückner, JERALD C. SADOFF, Barbara L. Banbury, Nicholas K. Akers, Bryan Howie, Harlan S. Robins, Griet A. Van Roey, Jeroen T. B. M. Tolboom et al. · 2025 · EBioMedicine
94. Adaptive immune responses to SARS-CoV-2
    Donald N. Forthal · 2021 · Advanced Drug Delivery Reviews
95. Could Antigen Presenting Cells Represent a Protective Element during SARS-CoV-2 Infection in Children?
    Rita Lauro, Natasha Irrera, Ali Hussein Eid, Alessandra Bitto · 2021 · Pathogens
96. A Promising Vaccination Strategy against COVID-19 on the Horizon: Heterologous Immunization
    Sameer-ul-Salam Mattoo, Jinjong Myoung · 2021 · Journal of Microbiology and Biotechnology
97. Comprehensive Analysis of CD4+ T Cell Response Cross-Reactive to SARS-CoV-2 Antigens at the Single Allele Level of HLA Class II
    You‐Seok Hyun, Yong‐Hun Lee, Hyeong-A Jo, In‐Cheol Baek, Sun-Mi Kim, Hyun‐Jung Sohn, Tai‐Gyu Kim · 2022 · Frontiers in Immunology
98. Post-COVID-19 Fatigue and SARS-CoV-2 Specific Humoral and T-Cell Responses in Male and Female Outpatients
    Christa Meisinger, Yvonne Goßlau, Tobias Dominik Warm, Vincenza Leone, Alexander Hyhlik-Dürr, Jakob Linseisen, Inge Kirchberger · 2022 · Frontiers in Immunology
99. Gold nanoparticles capped DHPMs for meliorate detection of antiretroviral drug: Azidothymidine
    Geetika Bhardwaj, Randeep Kaur, Navneet Kaur, Narinder Singh · 2022 · Talanta
100. Cellular heterogeneity in disease severity and clinical outcome: Granular understanding of immune response is key
     Kriti Khare, Rajesh Pandey · 2022 · Frontiers in Immunology